1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Association of abnormal WMHI and characteristics in 149 patients with fCCMa
fCCM Characteristic Abnormal WMHI (n = 23) Normal WMHI (n = 126) P Value Sex (No.) (%) Female 18 (78) 75 (60) .11 Male 5 (22) 51 (40) Age (yr) (mean) (SD) 23 (41) 32 (16) .01 Headaches (No.) (%) Yes 15 (65) 79 (64) 1.00 No 8 (35) 45 (36) Seizures (No.) (%) Yes 11 (48) 48 (39) .49 No 12 (52) 76 (61) Thyroid (No.) (%) Yes 3 (13) 9 (7) .40 No 20 (87) 115 (93) Diabetes (No.) (%) Yes 2 (9) 12 (10) 1.00 No 21 (91) 112 (90) Hyperlipidemia (No.) (%) Yes 7 (30) 17 (13) .06 No 16 (70) 109 (87) Hypertension (No.) (%) Yes 6 (26) 15 (12) .10 No 17 (74) 109 (88) Modified Rankin Scale (No.) (%) 0 4 (17) 46 (37) .33 1 10 (44) 37 (30) 2 7 (30) 27 (22) 3 2 (9) 11 (9) 4 0 (0) 2 (2) CCM lesions Median (IQR) 29 (29) 11 (39) .08 Mean (SD) 60 (122) 42 (96)
Note:—IQR indicates interquartile range.
↵a Note that some numbers for characteristics do not add up to column totals due to missing data.